SEC Form 4 · accession 0001144204-15-034978
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas McNaughton
Officer — Interim CEO and CFO
Period of report
May 29, 2015
Accepted (ET)
Jun 1, 2015 · 8:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $1.84 | May 29, 2015 | A | 85,000 | A | — | May 29, 2025 | Common Stock, par value $0.01 per share | 85,000 | 85,000 | D |
Explanation of responses
- F1The option shares vested in four equal installments on May 29, 2016, 2017, 2018 and 2019.
Remarks
This form has been signed under power of attorney.